Skip to main content

Table 2 Clinical events during the 18 months follow-up period

From: Intracoronary infusion of Wharton’s jelly-derived mesenchymal stem cells in acute myocardial infarction: double-blind, randomized controlled trial

Event

Placebo

WJMSCs

P value

Events during procedure

(n=58)

(n=58)

 

 Death

0

0

 

 Obstruction of related-vessel

0

0

 

 Severe arrhythmia

0

0

 

Events 6-mo follow-up (cumulative) a

(n=57)

(n=58)

 

 Death

1

0

0.49b

 Recurrence MI

0

0

 

 Rehospitalization for heart failure

0

1

1.0b

 Stent thrombosis

0

0

 

 Revascularization

0

1

1.0b

 Cerebral infarction

0

0

 

 Arrhythmia

0

0

 

 Immune system disorder

   

 Ectopic tissue formation

0

1

1.0b

Combined events

   

 Death or MI

1

0

0.49b

 Death, recurrence of MI, revascularization procedure

1

1

1b

 Death, MI, or rehospitalization for heart failure

1

1

1b

 Death, MI, stroke, rehospitalization for heart failure, severe arrhythmia

1

1

1b

 Immune system disorder, ectopic tissue formation

0

1

1b

Events 12-mo follow-up (cumulative)

   

 Death

1

0

0.49b

 Recurrence MI

0

0

 

 Rehospitalization for heart failure

0

1

1.0b

 Stent thrombosis

0

0

 

 Revascularization

0

1

1.0b

 Cerebral infarction

0

0

 

 Arrhythmia

0

0

 

 Immune system disorder

0

0

 

 Ectopic tissue formation

1

1

1.0b

Combined events

   

 Death or MI

1

0

0.49b

 Death, recurrence of MI, revascularization procedure

1

1

1b

 Death, MI, or rehospitalization for heart failure

1

1

1b

 Death, MI, stroke, rehospitalization for heart failure, severe arrhythmia

1

1

1b

 Immune system disorder, ectopic tissue formation

1

1

1b

Events 18-mo follow-up (cumulative)

   

 Death

1

0

0.49b

 Recurrence MI

0

0

 

 Rehospitalization for heart failure

0

1

1.0b

 Stent thrombosis

0

0

 

 Revascularization

0

1

1.0b

 Cerebral infarction

0

0

 

 Arrhythmia

0

0

 

 Immune system disorder

0

0

 

 Ectopic tissue formation

1

1

1.0b

Combined events

   

 Death or MI

1

0

0.49b

 Death, recurrence of MI, revascularization procedure

1

1

1b

 Death, MI, or rehospitalization for heart failure

1

1

1b

 Death, MI, stroke, rehospitalization for heart failure, severe arrhythmia

1

1

1b

 Immune system disorder, ectopic tissue formation

1

1

1b

  1. a1 Patient was lost in the placebo group. bFisher’s exact test was used
  2. MI myocardial infarction